Study finds weight loss drug semaglutide reduced COVID-19 related deaths during the pandemic

Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an international study led by researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, finds.

Source: Medical Xpress

Read more